Stocks · Health care · Biological Products, (No Diagnostic Substances)

RECURSION PHARMACEUTICALS, INC.

RXRX Clue Score60

United States Fiscal year ends December CIK 0001601830 Results filed 2 Nov 2026

Add to watchlist

What the insiders did Net buying

Bought (120 mo)

$64.70M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$66.75M

$11.38M on a plan · $49.12M straight out of an exercise

Sold at will

$6.25M

56 of 421 sales

Net

−$2.05M

+$58.45M against sales at will